IndexIQ Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

IndexIQ Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,534	Closed	-$676K	–	1158
2021 Q2	$676K	Sell	24,534 -442	-2%	-$8.69K	0.02%	368
2021 Q1	$412K	Buy	+24,976	New	+$569K	0.01%	504

IndexIQ Advisors's TBIO Position: Q3 2021 in Review

IndexIQ Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 24,534 shares — an estimated $676K sold.

IndexIQ Advisors first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $676K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

IndexIQ Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
IndexIQ Advisors sold 24,534 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $676K.
IndexIQ Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
IndexIQ Advisors's Translate Bio, Inc. Common Stock position peaked at $676K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on IndexIQ Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.